Department of Otorhinolaryngology Head and Neck Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami, Sagamihara, Kanagawa, 252-0375, Japan.
School of Allied Health Science, Kitasato University, 1-15-1 Kitasato, Minami, Sagamihara, Kanagawa 252-0375, Japan.
Auris Nasus Larynx. 2023 Oct;50(5):708-713. doi: 10.1016/j.anl.2023.01.004. Epub 2023 Feb 14.
Some studies have directly compared the National Acoustic Laboratories' prescription for non-linear hearing aids (HAs) version 2 (NAL-NL2) and Desired Sensation Level for non-linear HAs version 5 (DSLv5), although none were performed in Japan. As the Japanese language is a tonal language that has different linguistic characteristics than those of the studied languages, we compared the outcomes of the NAL-NL2 and DSLv5 in hearing-impaired Japanese participants.
A crossover-controlled trial was conducted on 18 first-time HA users with bilateral moderate sensorineural hearing loss. Participants wore HAs adjusted with each prescriptive method for four weeks. The prescriptions were assessed using speech discrimination testing and the abbreviated profile of hearing aid benefit (APHAB). Consequently, participants were asked to select their preferred prescription and determine which was better for "listening to a conversation" and when "noisy."
The mean DSLv5 real ear insertion gain for an input level of 65 dB sound pressure level (SPL) was higher than that of the NAL-NL2 at 250 and 500 Hz. The average speech discrimination score was 78 ± 14% at a 65-dB SPL and 75 ± 17% at an 80-dB SPL for the NAL-NL2, and 79 ± 11% at a 65-dB SPL and 77 ± 17% at an 80-dB SPL for the DSLv5. These differences were not significant. No significant differences were observed in APHAB subscale scores between the two prescription methods. Ultimately, 11 (61%) and 7 (39%) participants preferred the NAL-NL2 and DSLv5, respectively, with no significant differences.
Although the gain of the NAL-NL2 is smaller than that of the DSLv5, both had the same hearing effect. Therefore, the NAL-NL2 may be more useful than the DSLv5 in Japanese.
一些研究已经直接比较了国家声学实验室的非线性助听器处方 2 版(NAL-NL2)和非线性助听器期望感觉水平 5 版(DSLv5),尽管这些研究都没有在日本进行。由于日语是一种声调语言,与研究语言具有不同的语言特征,因此我们比较了 NAL-NL2 和 DSLv5 在日本听力受损参与者中的结果。
对 18 名首次佩戴双侧中度感音神经性听力损失的助听器使用者进行了交叉对照试验。参与者佩戴两种处方方法调整后的助听器各四周。使用言语辨别测试和简化助听器效果问卷(APHAB)评估处方。然后,让参与者选择他们更喜欢的处方,并确定哪种处方更适合“听对话”和“嘈杂环境”。
输入声压级为 65 分贝时,DSLv5 真耳插入增益的平均值高于 NAL-NL2 在 250 和 500 赫兹时的增益。NAL-NL2 在 65 分贝 SPL 时的平均言语辨别得分为 78±14%,在 80 分贝 SPL 时为 75±17%,DSLv5 在 65 分贝 SPL 时为 79±11%,在 80 分贝 SPL 时为 77±17%。这些差异没有统计学意义。两种处方方法的 APHAB 子量表得分没有显著差异。最终,11 名(61%)和 7 名(39%)参与者分别更喜欢 NAL-NL2 和 DSLv5,差异无统计学意义。
虽然 NAL-NL2 的增益小于 DSLv5,但两者的听力效果相同。因此,NAL-NL2 在日语中可能比 DSLv5 更有用。